Nue Life vs athenahealth
Side-by-side comparison of AI visibility scores, market position, and capabilities
Telehealth platform for ketamine-assisted therapy for treatment-resistant depression and PTSD; oral ketamine with coaching at home; licensed physician oversight with published outcomes data.
About
Nue Life is a Miami-based mental health company that provides at-home ketamine-assisted therapy for treatment-resistant depression, anxiety, PTSD, and OCD through a telehealth model. The company pairs oral ketamine with therapeutic coaching and integration support to treat patients who have not responded to traditional antidepressants. Nue Life's model addresses barriers to ketamine therapy — geographic access to ketamine clinics and prohibitive out-of-pocket costs — by delivering treatment at home with telehealth physician oversight and licensed therapist integration support. The platform has treated thousands of patients with documented outcomes data and published case studies. Nue Life operates in the rapidly growing psychedelic-assisted therapy market, which has seen significant clinical validation for ketamine and clinical trial progress for MDMA and psilocybin. Founded in 2020, the company has raised funding to expand access to ketamine therapy while the regulatory environment for psychedelic medicine continues to evolve.
$1.7B annual revenue; 160K+ providers, 117M patients; 18.15% EHR market share; 6,713+ companies using 2025; acquired by Bain Capital & Hellman & Friedman Nov 2021 at $17B; AI interoperability 2025
About
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on the principle that healthcare administration should be managed as a service — with athenahealth absorbing the complexity of payer rule updates, regulatory compliance, and billing workflows so that physicians and clinical staff can focus entirely on patient care. Its cloud-native architecture, deployed before most EHR competitors moved to the cloud, remains a core technical differentiator.\n\nathenahealth's platform — athenaOne — integrates EHR, revenue cycle management, patient engagement, and care coordination in a single system used by over 160,000 providers across 117 million patient records. The company serves ambulatory practices ranging from solo physicians to large health systems and medical groups. Its continuously updated rules engine processes millions of payer transactions daily, enabling higher clean claim rates and faster reimbursement compared to on-premise EHR alternatives. athenahealth holds an 18.15% share of the US ambulatory EHR market.\n\nathenahealth is currently owned by a private equity consortium of Bain Capital and Hellman & Friedman, which acquired the company in 2019 for $5.7 billion. Annual revenue stands at approximately $1.7 billion. The company competes with Epic, eClinicalWorks, and Oracle Health in the ambulatory EHR market. Its managed-service model, shared payer network data, and cloud-native infrastructure continue to make it a compelling choice for ambulatory providers who prioritize revenue cycle performance and reduced administrative burden.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.